货号:A714436
同义名:
马兜铃酸
/ Aristolochic acid I; TR 1736
Aristolochic acid A是一种从马兜铃科植物(Aristolochia debilis Sieb. et Zucc.)中提取的天然产物,强烈引起卵巢成熟过程中通过抑制Akt磷酸化介导的凋亡抑制的毒性损伤。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | NF-κB ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ammonium pyrrolidine-1-carbodithioate | ✔ | 98% | |||||||||||||||||
| QNZ |
++++
NF-κB, IC50: 11 nM |
99%+ | |||||||||||||||||
| Sodium 4-Aminosalicylate Dihydrate | ✔ | 98% | |||||||||||||||||
| Sodium Salicylate | ✔ | 95% | |||||||||||||||||
| Parthenolide | ✔ | p53 | 97% HPLC | ||||||||||||||||
| JSH-23 |
+
NF-κB, IC50: 7.1 μM |
98% | |||||||||||||||||
| Phenethyl caffeate | ✔ | 98% | |||||||||||||||||
| Andrographolide | ✔ | 98+% | |||||||||||||||||
| Curcumin | ✔ | HDAC,Nrf2 | 98% | ||||||||||||||||
| SC75741 |
+++
NF-κB, EC50: 200 nM |
99%+ | |||||||||||||||||
| CBL0137 HCl |
++
NF-κB, EC50: 0.47 μM |
p53 | 99%+ | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Aristolochic Acid A (Aristolochic acid I), is the main component of plant extract Aristolochic acids, which are found in various herbal plants of genus Aristolochia and Asarum, strongly induces toxic damage during ovarian maturation by inhibiting Akt phosphorylation-mediated suppression of apoptosis. Aristolochic acid A (150, 200 μM, 24 hours) inhibits the cell viabilities of kidney cells HEK293 and HK-2. Aristolochic acid A (100, 200 μM, 24 hours) causes a concentration-dependent decrease in bladder cancer-associated protein (BLCAP) mRNA levels in kidney cells (HEK 293 and HK-2), and bladder cancer cell line (HT-1376). Aristolochic acid A (100, 200 μM, 24 hours) weakens the BLCAP protein signals in a dose-dependent manner in both HEK293 and HT-1376 cells[3]. AA (Aristolochic Acid A) has been found to damage broilers' kidneys by breaking the redox balance to form oxidative stress, along with promoting apoptosis of renal cells[4]. Additionally, AAI promoted apoptosis in SSCs, which was accompanied by upregulation of caspase 3, P53 and BAX expression and downregulation of Bcl-2 expression, and suppressed autophagy, which was accompanied by upregulation of P62 expression and downregulation of ATG5 and LC3B expression, in a concentration-dependent manner. AAI (Aristolochic acid I) impaired spermatogenesis in rats, as identified by degeneration of the seminiferous epithelium, and increased apoptosis of testicular cells[5]. The mechanism of AA-I-induced hepatotoxicity was associated with oxidative-stress-mediated apoptosis and mitochondrial damage[6]. |
| Concentration | Treated Time | Description | References | |
| Bone marrow-derived macrophages (BMDMs) | 10 mg/ml | 0, 6, 12, 24, 48 hours | To study the effect of AA on macrophage polarization, results showed that AA treatment significantly increased the expression of M2-related genes. | Front Immunol. 2022 May 2;13:864984. |
| Raw264.7 cells | 10 mg/ml | 0, 6, 12, 24, 48 hours | To study the effect of AA on macrophage polarization, results showed that AA treatment significantly increased the expression of M2-related genes. | Front Immunol. 2022 May 2;13:864984. |
| Rat liver microsomes | 10 µM | 20 min | Investigation of AAI O-demethylation, identifying CYP1A and CYP2C subfamily as major catalysts | Int J Mol Sci. 2015 Nov 18;16(11):27561-75. |
| Human liver microsomes | 10 µM | 20 min | Investigation of AAI O-demethylation, identifying CYP1A1/2 and CYP3A4 as major catalysts | Int J Mol Sci. 2015 Nov 18;16(11):27561-75. |
| HEK293 cells | 20 µM | 24 hours | To validate KLF15 binding sites in the CPT1A and ACAA2 promoter regions by chromatin immunoprecipitation assay. Results showed that KLF15 binding to these promoter regions was maintained even after AAI treatment. | Kidney Int. 2021 Dec;100(6):1250-1267. |
| HK-2 cells | 20 µM | 24 hours | To evaluate the protective effect of KLF15 overexpression on AAI-induced cell injury. Results showed that KLF15 overexpression partially rescued the loss of FAO in AAI-treated cells. | Kidney Int. 2021 Dec;100(6):1250-1267. |
| NRK52E cells | 40 µM | 24 hours | To investigate the ameliorative effect of LYC on AAI-induced renal fibrosis and its mechanism. The results showed that LYC intervention activated mitophagy, reduced AAI-induced mitochondrial damage, and improved renal fibrosis by inhibiting the AKT signaling pathway. | Autophagy. 2024 May;20(5):1114-1133. |
| Human renal proximal tubular epithelial cell line (HK-2) | 100 µM | 24 hours | Evaluate the inhibitory effect of AAI on cell proliferation and DNA damage, SFII significantly alleviated AAI-induced DNA damage and apoptosis. | Acta Pharmacol Sin. 2023 Jul;44(7):1429-1441. |
| Human normal liver cell line (L02) | 20 µM, 50 µM | 24 hours, 48 hours | Evaluate the inhibitory effect of AAI on cell proliferation and DNA damage, SFII significantly alleviated AAI-induced DNA damage and apoptosis. | Acta Pharmacol Sin. 2023 Jul;44(7):1429-1441. |
| HK-2 cells | 5 µM and 10 µM | 4 hours | To study AAI-induced mitochondrial acidification, results showed increased mitochondrial acidification with higher AAI concentrations. | Mater Today Bio. 2024 Sep 11;28:101240. |
| Supersomes™ (recombinant CYP enzymes expressed in insect cells) | 10 µM | Evaluation of cytochrome b5 effect on AAI oxidation, identifying human CYP1A1 and 1A2 as major enzymes for AAI oxidation | Int J Mol Sci. 2015 Nov 18;16(11):27561-75. | |
| Administration | Dosage | Frequency | Description | References | ||
| Sprague-Dawley rats | Hepatocellular carcinoma model | Oral | 0.1, 1, or 10 mg/kg | 5 days a week for 6 weeks (medium-term study) or 52 weeks (long-term study) | To evaluate the tumor-initiating or -promoting activity of AAI. Results showed that high-dose AAI (10 mg/kg) promoted clonal expansion but did not induce HCC. | Acta Pharmacol Sin. 2021 Dec;42(12):2094-2105 |
| C57BL/6 mice | AAI-induced renal fibrosis model | Oral gavage | 10 mg/kg | Once daily for 28 days | To investigate the ameliorative effect of LYC on AAI-induced renal fibrosis and its mechanism. The results showed that LYC intervention alleviated AAI-induced renal histopathological damage, restored renal function, and improved renal fibrosis by inhibiting the TGFB signaling pathway and activating mitophagy. | Autophagy. 2024 May;20(5):1114-1133. |
| Mice | AAN model | Intraperitoneal injection | 10 mg/kg | 1, 3, 7, 14, 28 days | To study AA-induced renal fibrosis, results showed that AA treatment significantly increased renal fibrosis and macrophage M2 polarization. | Front Immunol. 2022 May 2;13:864984. |
| C57BL/6J mice | AAI-induced acute kidney injury model | Intraperitoneal injection | 10 mg/kg | Single injection, sacrificed after 3 days | To study the role of PSTPIP2 in AAI-induced acute kidney injury, it was found that conditional knock-in of Pstpip2 alleviated kidney injury and apoptosis. | Elife. 2024 Feb 5;13:e89740 |
| C57BL/6 mice | AAI-induced hepatotoxicity Mice model | Intraperitoneal injection | 2 mg/kg | Once daily for 4 weeks or 8 weeks | To investigate the mechanisms of AAI-induced hepatotoxicity, results showed that AAI exposure led to body weight loss, liver injury, inflammatory cell infiltration, and increased levels of ALT and AST. | Precis Clin Med. 2022 Sep 22;5(4):pbac023 |
| C57 BL/6 mice | AA-induced nephrotoxicity model | Intraperitoneal injection | 2 mg/kg | Once a day for 4 weeks | Evaluate AA-induced nephrotoxicity and metabolic disorders | Int J Biol Sci. 2022 Feb 21;18(5):2003-2017 |
| Sprague-Dawley rats | Hepatocellular carcinoma model | Oral | 20, 50, or 100 mg/kg | Single dose | To evaluate the tumor-initiating or -promoting activity of AAI. Results showed that high-dose AAI (10 mg/kg) promoted clonal expansion but did not induce HCC. | Acta Pharmacol Sin. 2021 Dec;42(12):2094-2105 |
| Mice | AAI-induced nephrotoxicity model | Tail vein injection | 200 μM | Five times per week for two weeks | To study AAI-induced nephrotoxicity and mitochondrial acidification, results showed AAI caused renal injury and mitochondrial acidification, which was mitigated by LC co-treatment. | Mater Today Bio. 2024 Sep 11;28:101240. |
| C57BL/6 mice | Klf15PTKO mice | Intraperitoneal injection | 3 mg/kg | Every 3 days for 2 weeks | To evaluate the effect of PT-specific KLF15 deletion on AAI-induced kidney injury. Results showed that Klf15PTKO mice exhibited more severe tubular injury and kidney function decline after AAI treatment. | Kidney Int. 2021 Dec;100(6):1250-1267. |
| C57BL/6 mice | AAN model | Intraperitoneal injection | 3 mg/kg | Twice a week for 4 weeks followed by 4 weeks of remodeling time | To investigate whether AA induces renal aging, results showed AA caused renal atrophy, tubulointerstitial fibrosis, and renal functional decline, accompanied by increased renal p16 mRNA expression and SA-β-gal activity | Int J Mol Sci. 2021 Nov 18;22(22):12432 |
| Mice | Trp53(+/+), Trp53(+/-), and Trp53(-/-) mice | Intraperitoneal injection | 3.5 mg/kg | Daily for six days | To investigate the impact of p53 on AAI-induced gene expression in vivo, results showed that AAI significantly altered gene expression in kidneys of Trp53(+/+), Trp53(+/-), and Trp53(-/-) mice | Int J Mol Sci. 2019 Dec 6;20(24):6155 |
| C57BL/6 mice | Acute renal injury model and renal fibrosis model | Intraperitoneal injection | 5 mg/kg, 10 mg/kg | Three consecutive days or 14 days after a single dose | Evaluate the protective effect of SFII on AAI-induced renal injury and fibrosis, SFII effectively attenuated acute renal injury and fibrosis caused by AAI in vivo. | Acta Pharmacol Sin. 2023 Jul;44(7):1429-1441. |
| Animal study | 肾毒性[5] 动物: BALB/c 小鼠,~20 g。 给药:10 mg/kg/天,腹腔注射,3-5天。 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT03066921 | End Stage Renal Disease | Not Applicable | Completed | - | Taiwan ... 展开 >> Tungs' Taichung MetroHarbour Hospital Taichung, Taiwan 收起 << |
| NCT01503645 | - | Unknown | - | Taiwan ... 展开 >> Far Estern Memorial Hospital Not yet recruiting Pan-Chiao, Taipei, Taiwan, 22060 National Taiwan University Hospital Recruiting Taipei, Taiwan, 10051 Contact: Kwan-Dun Wu, MD, PhD +886-2-23123456 ext 5014 kdw@ntumc.org Principal Investigator: Fe-Lin L Wu, Ph.D. 收起 << | |
| NCT00867633 | - | Unknown | March 2012 | Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Yeong-Shiau Pu, Ph.D. 886-2-23123456 ext 65249 yspu@ntu.edu.tw 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.93mL 0.59mL 0.29mL |
14.65mL 2.93mL 1.47mL |
29.30mL 5.86mL 2.93mL |
|
| CAS号 | 313-67-7 |
| 分子式 | C17H11NO7 |
| 分子量 | 341.27 |
| SMILES Code | O=C(C1=CC(OCO2)=C2C3=C4C=CC=C(OC)C4=CC([N+]([O-])=O)=C13)O |
| MDL No. | MFCD00004996 |
| 别名 | 马兜铃酸 ;Aristolochic acid I; TR 1736; AristA; Birthwort; Tardolyt; NSC 50413; NSC 11926; Aristolochic Acid; Aristolochine; Aristolochin |
| 运输 | 蓝冰 |
| InChI Key | BBFQZRXNYIEMAW-UHFFFAOYSA-N |
| Pubchem ID | 2236 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 16 mg/mL(46.88 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1